We came across a bullish thesis on Mereo BioPharma Group plc (MREO) on Raging Bull Investments’ Substack by Jake LaMotta. In this article we will summarize the bulls’ thesis on MREO. Mereo BioPharma Group plc (MREO) share was trading at $3.95 as of Sept 17th.
[caption id="attachment_904172" align="aligncenter" width="450"]Mereo BioPharma is positioning itself as a key player in rare diseases, with Ultragenyx recently providing a highly optimistic update on setrusumab’s phase 3 trials for osteogenesis imperfecta (OI). The updated 14-month phase...
Create a free account, or log in to read the full article
No credit card required.
We may use your email to send marketing emails about our services. Click here to read our privacy policy.